
Center for Autism and Related Disorders (CARD) and Lineagen, Inc. today announced the launch of a new clinical partnership to offer Lineagen’s FirstStepDx® genetic test to patients and their families. FirstStepDx is a whole-genome genetic test customized with validated, novel proprietary genetic variants associated with ASDs. Under the terms of the partnership agreement, FirstStepDx, integrated with a pre-and post-test genetic counseling service and personalized reporting, will be offered to patients receiving treatment in CARD’s innovative Skills® program. The program is the first of its kind, designed to fully meet current clinical guidelines that recommend chromosomal microarray analysis as a first-line genetic test as part of a comprehensive diagnostic evaluation of individuals with ASDs.
The A-Word, Part 49: New Therapist Trianing w/ Christine
After a new therapist has completed 20 hours of elearning from CARD’s online training program and practiced what they have learned with a supervisor in the office, they then go out into the field and do overlaps with a senior therapist like Jessica. Today, Jack Riley and Jessica show Christine what it’s like to work with a child that has autism.